Market Activity: TTM Technologies Announces Expansion, Alignment Healthcare Shares Rise
What happened
TTM Technologies dropped 11% to $107 per share after announcing a $400 million investment to expand capacity across four facilities in China and its plant in Penang, Malaysia. Alignment Healthcare's shares increased 9.7% to $8.27 during midday trading after announcing a new plan, Central Health Harmony (HMO), launching on January 1, 2027, in Los Angeles and Orange counties. Separately, Karman Space & Defense fell 4.7% to $30.40, and Rocket Lab was down 2.6% at $64.06, according to.
From ocbj.com
Why it matters
The investment by TTM Technologies signals a significant capital commitment to expand manufacturing capacity in Asia. Alignment Healthcare's new plan launch could affect demand for Medicare Advantage services in specific California counties.
From ocbj.com
Who's involved
Keep exploring
The entities involved
Related events
- FDA approval enables commercial availability for a product associated with Indianapolis.
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- FDA approval expands patient access to therapies for ACCORD.
- Litigation regarding FDA approval process.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.